Cost-Effectiveness of Cognitive-Behavioural Therapy for Mental Disorders: Implications for Public Health Care Funding Policy in Canada
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Objective: Publicly funded cognitive-behavioural therapy (CBT) for mental disorders is scarce in Canada, despite proven efficacy and guidelines recommending its use. This paper reviews published data on the economic impact of CBT to inform recommendations for current Canadian mental health care funding policy. Method: We searched the literature for economic analyses of CBT in the treatment of mental disorders. Results: We identified 22 health economic studies involving CBT for mood, anxiety, psychotic, and somatoform disorders. Across health care settings and patient populations, CBT alone or in combination with pharmacotherapy represented acceptable value for health dollars spent, with CBT costs offset by reduced health care use. Conclusions: International evidence suggests CBT is cost-effective. Greater access to CBT would likely improve outcomes and result in cost savings. Future research is warranted to evaluate the economic impact of CBT in Canada. Objectif: La thérapie cognitivo-comportementale (TCC) financée par l'État pour les troubles mentaux est rare au Canada, malgré son efficacité prouvée et les lignes directrices qui la recommandent. Cet article examine les données publiées sur l'effet économique de la TCC afin d'éclairer les recommandations en vue des politiques canadiennes actuelles de financement des soins de santé mentale. Méthode: Dans la documentation, nous avons recherché des analyses économiques de la TCC dans le traitement des troubles mentaux. Résultats: Nous avons repéré 22 études économiques de la santé faisant appel à la TCC des troubles de l'humeur, anxieux, psychotiques et somatoformes. Dans les établissements de santé et parmi les populations de patients, la TCC seule ou combinée avec la pharmacothérapie représentait une valeur acceptable pour les fonds de santé dépensés, car les coûts de la TCC sont compensés par une utilisation réduite des soins de santé. Conclusions: Les données probantes internationales suggèrent que la TCC est rentable. Un meilleur accès à la TCC améliorerait probablement les résultats et se traduirait par des épargnes. Il faut plus de recherche pour évaluer l'effet économique de la TCC au Canada.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The quality of care for depressive and anxiety disorders in the United States
Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.55 · Cited by 1,061
Andrews, G., Henderson, S., & Hall, W. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.145 · Cited by 933 · cited 1×
“In primary care, individuals with depression receive optimal care only one-half the time (16,17), whereas those with anxiety are optimally treated even less frequently (18,19).”
BackgroundWang, P. S., Berglund, P., & Kessler, R. C. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.9908044.x · Cited by 686 · cited 1×
“In primary care, individuals with depression receive optimal care only one-half the time (16,17), whereas those with anxiety are optimally treated even less frequently (18,19).”
BackgroundA meta-analysis of treatment outcome for panic disorder
Gould, R. A., Ott, M. W., & Pollack, M. H. (1995) · Clinical Psychology Review · doi:10.1016/0272-7358(95)00048-8 · Cited by 520
Turkington, D., Kingdon, D., & Turner, T. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.6.523 · Cited by 350 · cited 1×
“Advantages of CBT over pharmacotherapy include fewer dropouts (10) and relapses (11), higher satisfaction (12), and fewer side effects.”
BackgroundUnequal access and unmet need: neurotic disorders and the use of primary care services
BEBBINGTON, P. E., MELTZER, H., BRUGHA, T. S., FARRELL, M., JENKINS, R., CERESA, C., & LEWIS, G. (2000) · Psychological Medicine · doi:10.1017/s0033291799002950 · Cited by 229
The National Psychiatric Morbidity Surveys of Great Britain – strategy and methods
JENKINS, R., BEBBINGTON, P., BRUGHA, T., FARRELL, M., GILL, B., LEWIS, G., MELTZER, H., & PETTICREW, M. (1997) · Psychological Medicine · doi:10.1017/s003329179700531x · Cited by 153
Cost-Effectiveness of Cognitive–Behavioural Therapy and Drug Interventions for Major Depression
Vos, T., Corry, J., Haby, M. M., Carter, R., & Andrews, G. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01652.x · Cited by 114
ISSAKIDIS, C., SANDERSON, K., CORRY, J., ANDREWS, G., & LAPSLEY, H. (2004) · Psychological Medicine · doi:10.1017/s003329170300881x · Cited by 110 · cited 16×
“A third Australian study evaluated cost-effectiveness of treatment for children and adolescents with MDD (42).”
BackgroundResultInfluentialSTARTUP, M., JACKSON, M. C., EVANS, K. E., & BENDIX, S. (2005) · Psychological Medicine · doi:10.1017/s0033291705005003 · Cited by 43
Cited by
Mental Health Service Provision in Low- and Middle-Income Countries
Rathod, S., Pinninti, N., Irfan, M., Gorczynski, P., Rathod, P., Gega, L., & Naeem, F. (2017) · Health Services Insights · doi:10.1177/1178632917694350 · Cited by 866
Mind the gap: improving the dissemination of CBT
Shafran, R., Clark, D. M., Fairburn, C. G., Arntz, A., Barlow, D. H., Ehlers, A., Freeston, M., Garety, P. A., Hollon, S. D., Ost, L. G., et al. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.07.003 · Cited by 569
The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial: A Review
Sinyor, M., Schaffer, A., & Levitt, A. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500303 · Cited by 396
Hedman, E., Ljótsson, B., Andersson, E., Rück, C., Andersson, G., & Lindefors, N. (2010) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2010.496460 · Cited by 49
Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial
Smit, F., Willemse, G., Meulenbeek, P., Koopmanschap, M., van Balkom, A., Spinhoven, P., & Cuijpers, P. (2009) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-7-8 · Cited by 48
Metadata
- Authors
- Myhr, G., & Payne, K.
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2006-09
- Volume
- 51
- Issue
- 10
- Pages
- 662-670
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- OpenAlex
- W2130918319
- Cited by
- 88
- References
- 10
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-Effectiveness of Cognitive-Behavioural Therapy for Mental Disorders: Implications for Public Health Care Funding Policy in Canada. https://app.cochat.ai/papers/10.1177/070674370605101006
- The paper
- Myhr, G., & Payne, K. (2006). Cost-Effectiveness of Cognitive-Behavioural Therapy for Mental Disorders: Implications for Public Health Care Funding Policy in Canada. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674370605101006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.